,,ii  #aafth ,,congress  #ast ,session  
,s4 #dai  ,,in ,,the ,,senate ,,of ,,the
 ,,united ,,states  ,february #g1       
#bjai,mr4 ,manchin introduced the       
following bill2 which was read twice and
 referred to the ,committee on ,health1 
,education1 ,labor1 and ,pensions  ,a   
,,bill  ,to require the ,food and ,drug 
,administration to revoke the approval  
of one opioid pain medication for each  
new opioid pain medication approved4    
#a4 ,short title ,this ,act may be cited
 as the ,protecting ,americans from     
,dangerous ,opioids ,act4  #b4 ,findings
 ,congress finds as follows3 7#a7       
,opioids killed more than #cc1jjj people
 in the ,united ,states in #bjae1 more  
than any year on record4 ,nearly half of
 all opioid overdose deaths involve a   
prescription opioid4  7#b7 ,according to
 the ,centers for ,disease ,control1 #c 
out of #d new heroin users abused       
prescription opioids before moving to   
heroin4  7#c7 ,the ,united ,states makes
 up only #d4f percent of the world's    

population1 but consumes #hj percent of 
its opioid pain medications4  7#d7 ,in  
#bjab1 health care providers wrote      
#bei1jjj1jjj prescriptions for          
painkillers1 enough for every individual
 in the ,united ,states to have a bottle
 of pills4  7#e7 ,the amount of         
prescription opioids sold in the ,united
 ,states has nearly quadrupled since    
#aiii without a reported increase in    
pain4 ,at the same time overdose deaths 
involving opioids have also quadrupled  
since #aiii4  #c4 ,requirement to revoke
 approval  7a7 ,in general              
,notwithstanding any other provision of 
law1 if the ,secretary of ,health and   
,human ,services 7referred to in this   
section as the ,secretary7 approves an  
application under subsection 7b7 or 7j7 
of section #eje of the ,federal ,food1  
,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4
 #cee7 for an opioid drug1 the          
,secretary shall revoke the approval of 
another opioid drug previously approved 
under such subsection 7b7 or 7j74  7b7  

,considerations ,in determining the drug
 for which the ,secretary will revoke   
approval pursuant to subsection 7a71 the
 ,secretary shall--  7#a7 prioritize    
revocation of non-abuse deterrent       
formulations of opioid drugs2 and  7#b7 
consider the public health impact of the
 opioid drug being on the market4